Response to recombinant yeast-derived hepatitis B vaccine in Arab infants

International Journal of Risk and Safety in Medicine

Volumn 12, Issue 3-4, 1999, Pages 193-196

  Jaber, L ^a,d   Merlob, P ^b,c   Samra, Z ^b,c  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d Rabin Medical Center ^*  (Israel)

Author keywords

Antibodies persistence; Hepatitis B vaccine; Immune response

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT VACCINE;

ANTIBODY TITER; ARTICLE; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEPATITIS B; HUMAN; IMMUNE RESPONSE; INFANT; ISRAEL; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SEROCONVERSION; TREATMENT OUTCOME; VACCINATION;

EID: 0033490878     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. M. Just, R. Berger and N. Scheiermann, Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine, Vaccine 6 (1988), 401-402.
2. J.E. Maynard, M.E. Kane, M.J. Alter and S.C. Hadler, Control of hepatitis B by immunization: global perspective, in: Viral Hepatitis and Liver Disease, A.J. Zuckerman, ed., New York, Liss Inc., 1988, pp. 967-969.
3. A. Belson, S. Reif, Y. Peled and Y. Bojanover, Immune response to hepatitis B virus vaccine in 1-year-old preterm and term infants, J. Pediatr. Gastroenterol. Nutr. 23(3) (1996), 252-255.
4. P. Coursaget, D. Leboulleux, M. Soumare et al., Twelve-year follow-up study of hepatitis B immunization of Senegalese infants, J. Hepatol. 21 (1994), 250-254.
5. J. Goldfarb, S.V. Medendorp, H. Garcia, K. Nagamori, H. Rathfon and D. Krause, Comparison study of the immunogenicity and safety of 5 and 10 μg dosage of recombinant hepatitis B vaccine in healthy infants, Pediatr. Infect. Dis. J. 15 (1996), 264-267.
6. N. Scheiermann, Immunization with a recombinant hepatitis B vaccine (Engerix B) - 5-year follow-up results (Abstract), 1990 International Symposium on Viral Hepatitis and Liver Disease, 1990, Houston, Texas, #112.
7. C.E. Stevens, P.T. Toy, P.E. Taylor et al., Prospects for control of hepatitis B virus infection: implication of childhood vaccination and long-term protection, Pediatrics 90 (1992), 170-173.
8. A.R. Zanetti, E. Tanzi, A. Pozzi, L. Romano and F. Bergamini, Yeast-derived hepatitis B vaccine in dental students: a 3-year follow-up study, Vaccine 8(3) (1990), 205-208.
9. C.A. Alper, M.S. Kruskall, D. Marcus-Bagley et al., Genetic predisposition of nonresponse to hepatitis B vaccine, N. Engl. J. Med. 21 (1989), 708-712.
10. W.F. Carman, H. Thomas and E. Domingo, Viral genetic variation: hepatitis virus, a clinical example, Lancet 341 (1993), 349-353.
11. W.F. Carman, A. Zanetti, P. Karayiannis et al., Vaccine-induced escape mutant of hepatitis B virus, Lancet 336 (1990), 325-329.
12. S.C. Hadler, Hepatitis B prevention and human immunodeficiency virus infection, Ann. Intern. Med. 109 (1988), 92-94.
13. S.C. Hadler and H.S. Margolis, Hepatitis B immunization: vaccine types, efficacy and indications for immunization, Curr. Clin. Topics Infect. Dis. 12 (1992), 282-308.
14. A.E. Reid and L.S. Friedman, Immunity to hepatitis B virus: passing the torch, Gastroenterology 106 (1994), 1388-1294.
15. H. Watanabe, S. Matsushita, N. Kumikawaji, K. Hirayama, M. Okumura and T. Sasazuki, Immune suppression gene on HLA-Bw54-DR4-DRw53 haplotype controls. Nonresponsiveness in humans to hepatitis B surface antigen via CD8+ suppressor T cells, Hum. Immunol. 22 (1988), 9-17.
16. D.J. West, B. Watson, J. Lichtman, T.M. Hesley and K. Hedberg, Persistence of immunologic memory for twelve years in children given hepatitis B vaccine in infancy, Pediatr. Infect. Dis. J. 13 (1994), 745-747.
17. 1997 Red Book Report of the Committee of Infectious Disease, 24th edn, American Academy of Pediatrics (AAP), p. 251.